Today: 12 April 2026
Morgan Stanley stock rises as Michael Grimes returns — and traders brace for jobs, CPI
9 February 2026
2 mins read

Morgan Stanley stock rises as Michael Grimes returns — and traders brace for jobs, CPI

New York, February 9, 2026, 14:15 ET — Regular session

  • Morgan Stanley shares climb roughly 2% in afternoon trading
  • The bank has turned to veteran dealmaker Michael Grimes, naming him head of investment banking.
  • IPO prospects and a fresh round of U.S. data this week still have traders weighing rate moves and deal activity.

Shares of Morgan Stanley climbed Monday, with the stock gaining $3.30 to trade at $183.26, up roughly 1.8% by mid-afternoon. Investors responded to the bank’s move to bring back Michael Grimes, a seasoned dealmaker, to head up investment banking.

This hire is key—the focus for major U.S. banks now turns to chasing bigger fee pools. Goldman Sachs analysts are betting that U.S. IPO proceeds could hit $160 billion in 2026, four times what they are now, if dealmaking picks up. Still, they warn that volatility and valuation risks could easily disrupt that forecast.

Stocks calmed down a bit after software names took a hit thanks to last week’s AI selloff, and with the Fed looming, traders are back on edge. “It’s an eye-popping number, $650 billion,” Anna Rathbun, founder and CEO of Grenadilla Advisory, said of Big Tech’s AI spending plans. On the near-term radar: January’s delayed nonfarm payrolls lands Wednesday, January CPI is out Friday, and Nvidia delivers results later this month. Reuters

According to the memo, Grimes, who just wrapped up a stint as senior adviser at the U.S. Commerce Department, spent over 30 years at Morgan Stanley. “Michael will continue to manage and build relationships with many of our most important global corporate, venture, private equity and sovereign clients,” the note said. He’s set up shop in Menlo Park, California. Grimes brings a history of high-profile IPOs—Meta, Uber—and has teamed with Elon Musk on both Tesla’s market debut and that $44 billion Twitter deal. Reuters previously named Morgan Stanley as a frontrunner for a possible SpaceX role. Investing.com South Africa

Morgan Stanley’s move speaks for itself: they’re bringing in a familiar tech dealmaker just as companies edge back toward public offerings. Investment banking fees swing with the deal calendar — that’s just how it goes — and the market hasn’t hesitated to factor those ups and downs straight into the stock.

In recent years, the bank has pushed further into its wealth business to help steady its results. Still, MS shares usually move with two familiar drivers: how much risk investors are willing to take, and the volume of deal activity—just like its rivals.

The action Monday lined up with the broader trend. As beaten-down tech names rebounded and investors rotated through sectors, broker-dealers caught a lift—even absent any fresh earnings news. More trading from clients, plus a little extra risk appetite from corporate boards, did the trick.

The flip side is just as clear. Should markets lurch back into volatility, or if this week’s data jolts rate expectations, private firms might simply pause, leaving M&A to drift into another “wait and see” stretch. Advisory and underwriting fees would take the hit—precisely when Wall Street’s still spending on bankers and tech.

Investors are scanning for any hints that the IPO window is cracking open, and staying alert to fresh signs the economy may be slowing enough to bring rate cuts forward. They’re also eyeing risk assets to see if last week’s jolt turns into something bigger.

Up next for Morgan Stanley: wealth management chief Jed Finn has a spot at the UBS Financial Services Conference on Tuesday. He’s slated to speak February 10 at 3:30 p.m. ET, and the bank will share a webcast.

Stock Market Today

  • Is ICON (NasdaqGS:ICLR) Undervalued Amid Recent Price Volatility?
    April 11, 2026, 9:07 PM EDT. ICON's stock closed at $106.81, rising 8.6% over 30 days but showing declines of 43.4% year-to-date and 25.8% over one year. The company operates as a contract research organization in healthcare, a sector currently under investor scrutiny. A Discounted Cash Flow (DCF) analysis values ICON at $222.42 per share, indicating a 52% discount to the current price and suggesting undervaluation. ICON's price-to-earnings (P/E) ratio stands at 13.61x, significantly lower than the Life Sciences industry average of 33.89x and its peers at 44.72x. These metrics imply the market may be pricing in risk or slower growth. Investors should consider these valuation factors alongside sector trends to assess whether ICON reflects a buying opportunity or ongoing volatility.

Latest article

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 9:07 PM EDT Is ICON (NasdaqGS:ICLR) Undervalued Amid Recent Price Volatility? April 11, 2026, 9:07 PM EDT. ICON's stock closed at $106.81, rising 8.6% over 30 days but showing declines of 43.4% year-to-date and 25.8% over one year. The company operates as a contract research organization in healthcare, a sector currently under investor scrutiny. A Discounted Cash Flow (DCF) analysis values ICON at $222.42 per share, indicating a 52% discount to the current price and suggesting undervaluation. ICON's price-to-earnings (P/E) ratio stands at 13.61x, significantly lower than the
Verizon stock pops as VZ nears a 52-week high on board update, rate watch
Previous Story

Verizon stock pops as VZ nears a 52-week high on board update, rate watch

Why Snowflake stock price is up today: Jefferies says AI fears are “too harsh”
Next Story

Why Snowflake stock price is up today: Jefferies says AI fears are “too harsh”

Go toTop